Autoimmune hepatitis: Of host and pathogen
β Scribed by Eirini I. Rigopoulou; George N. Dalekos
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 49 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
US screening that were well-defined and identified in two US projections. By using these requirements, we avoided the inclusion of patients with coarse, ill-defined, previously present nodules that correspond to regenerative nodules within a cirrhotic liver. If we had included patients with several nodules, the likelihood that one of them would correspond to HCC would have been higher. If we had to study them all at the same time, we would have had to biopsy all of them, which is a proposal that would not be acceptable, as Song will surely agree.
In summary, we hope that these comments have helped to clarify some of the controversies raised by Caturelli, de Sio, and Song, while also exposing the limitations and benefits that FNB offers in the diagnosis of early HCC. Current research efforts in genomics and proteomics may overcome the need of both pathology interpretation and imaging characterization, but in current clinical practice both tools have to be used in a complementary way.
π SIMILAR VOLUMES
G (IgG) concentration was 5622 mg/dL (normal range: 870-1700), and anti-nuclear antibody titer (1:20480), anti-double-stranded DNA (>400 IU/mL), and smooth muscle antibody titer (1:40) were all abnormal. Infection with hepatitis A, B, and C; cytomegalovirus; and Epstein-Barr virus were excluded, and
that for gibbon ape leukemia virus. Proc Natl Acad Sci U S A strategies requires the practitioner to evaluate care-1994;91:78-82. fully all relevant data before instituting therapy. In-7. Van Zeijl M, Johan SV, Closs E, Cunningham J, Eddy R, Shows appropriate treatment with interferon alfa may exa-T
Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.